Glenmark Pharmaceuticals reports over two-fold jump in Q3 consolidated net profit

03 Feb 2017 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2016.

The company has posted around three-fold jump in its net profit at Rs 711.31 crore for the quarter under review as compared to Rs 263.18 crore for the same quarter in the previous year. Total income of the company increased by 62.61% at Rs 2298.14 crore for the quarter under review as compared Rs 1413.28 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported over two fold rise in its net profit after tax, minority interest and share of profit of associates at Rs 477.03 crore for the quarter ended December 31, 2016, as compared to Rs 196.18 crore for the same quarter in the previous year. Total income of the company increased by 43.20% at Rs 2549.58 crore for the quarter under review as compared Rs 1780.43 crore for the corresponding quarter previous year. 

Glenmark Pharma Share Price

1986.75 -5.95 (-0.30%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×